Premium
A case series of 20 women with hidradenitis suppurativa treated with spironolactone
Author(s) -
Lee Andrew,
Fischer Gayle
Publication year - 2015
Publication title -
australasian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.67
H-Index - 53
eISSN - 1440-0960
pISSN - 0004-8380
DOI - 10.1111/ajd.12362
Subject(s) - hidradenitis suppurativa , medicine , spironolactone , series (stratigraphy) , dermatology , surgery , heart failure , disease , paleontology , biology
Hidradenitis suppurativa ( HS ) is an uncommon chronic skin condition that can range in severity from a single nodule to extensive disease and can have a profound effect on quality of life. Anti‐androgen medication has been suggested as a possible management strategy in female patients with HS and is mentioned in review articles as a treatment option. Despite this, there is limited literature documenting the use of anti‐androgens in HS . We present our experience with 20 patients with HS treated with oral spironolactone. We advocate spironolactone as a useful, low‐cost first‐line treatment for women with HS , with relatively few side‐effects.